The North America Minimally Invasive Surgery Market was valued at USD 15,700 Million in 2025 and is expected to reach USD 34,100 Million by 2035, growing at a CAGR of 7.2% from 2024 to 2035.
The economic impact of tariffs on "North America Minimally Invasive Surgery Market".
Market Growth Drivers
Rising Adoption of Robotic-Assisted Surgical Systems: Increasing adoption of robotic-assisted surgical platforms such as the da Vinci Surgical System by Intuitive Surgical has significantly boosted the accuracy and efficiency of minimally invasive procedures. The need for enhanced visualization and precision in complex surgeries, coupled with growing patient demand for quicker recovery and reduced hospital stays, is fueling the segment's growth. Intuitive Surgical reported a record shipment of over 1,300 da Vinci systems globally in 2023, with North America as a leading market.
Increasing Geriatric Population and Prevalence of Chronic Diseases: The aging population in North America and higher prevalence of chronic diseases like cancer, cardiovascular disorders, and orthopedic conditions are accelerating the demand for minimally invasive surgeries. Companies like Medtronic have introduced advanced minimally invasive instruments for cardiac and spinal surgeries, addressing the growing need for less invasive treatment options among the elderly. According to the U.S. Census Bureau, by 2030, one in five Americans will be 65 or older, boosting the market.
Market Trends
R&D Investment and Product Innovations: Leading companies such as Johnson & Johnson are investing heavily in R&D to develop next-generation minimally invasive surgical instruments and imaging technologies. The Ethicon division of J&J launched the ENSEAL X1 Curved Jaw Tissue Sealer in 2023, which offers improved efficiency and safety in laparoscopic procedures. These technological advancements are shaping procedural protocols and expanding the range of treatable conditions.
Growth in Outpatient and Ambulatory Surgical Centers: The transition from traditional inpatient hospital settings to outpatient and ambulatory surgical centers (ASCs) for minimally invasive surgeries is a significant trend. Companies like Stryker Corporation are focusing on customized solutions for ASCs, such as compact endoscopy systems, to cater to this growing market. This shift is driven by cost-effectiveness, convenience, and a focus on reducing patient length of stay.
Market Opportunity
Expansion in Training and Simulation Platforms: With the increasing complexity of new minimally invasive procedures, there is substantial opportunity for growth in simulation and training platforms. Companies like Surgical Science are enhancing their VR-based training solutions, enabling widespread adoption of advanced surgical techniques.
Untapped Rural Markets and Telemedicine Integration: Expanding access to minimally invasive procedures in rural areas through telemedicine consultations and remote-assisted surgeries presents a key opportunity. Companies such as Siemens Healthineers are actively piloting tele-assistance solutions to bridge skilled workforce gaps.
North America Minimally Invasive Surgery Market Revenue (USD Million), 2020-2035
The chart illustrates a steady growth trajectory in the North America Minimally Invasive Surgery Market from 2020 to 2035. Market revenue increased from USD 8,900 Million in 2020 to an estimated USD 15,700 Million in 2025. By 2030, it is projected to reach USD 23,500 Million, driven by rising adoption of minimally invasive techniques, technological advancements, and expansion in ambulatory surgery centers. By 2035, the market is forecasted to hit USD 34,100 Million, reflecting a strong CAGR of 7.2% over the period. This growth is underpinned by ongoing innovations and increasing demand for better patient outcomes.
North America Minimally Invasive Surgery Market by Region Share (%) in 2025
The pie chart shows the 2025 regional market share for minimally invasive surgery in North America. The United States dominates with 77% due to a well-established healthcare infrastructure and high technological adoption rates. Canada accounts for 16%, benefitting from increased healthcare funding and rapid integration of advanced surgical technologies. Mexico represents 5%, showing gradual uptake of minimally invasive procedures. Other regions contribute 2% combined, reflecting lower adoption rates. Overall, the regional distribution underscores the U.S.'s leadership role, with opportunities for growth in Canada and Mexico.
Recent Developments
In April 2024, Intuitive Surgical announced FDA clearance for its da Vinci 5 robotic surgery system, incorporating advanced haptic feedback and modular wristed instruments. This breakthrough is set to enhance surgeon dexterity and patient outcomes in delicate minimally invasive procedures, further strengthening Intuitive's market leadership in North America.
Johnson & Johnson's Ethicon division received Health Canada approval in March 2024 for its VISTASEAL Open Surgical Sealant, which can now be used across a wider range of minimally invasive procedures. The innovation is expected to improve hemostasis and reduce surgical complications in laparoscopic and thoracoscopic surgeries.
In May 2024, Medtronic launched its Mazor X Stealth robotic guidance platform at leading U.S. hospitals. The system integrates real-time imaging, navigation, and AI-powered analytics for spinal surgeries, marking a significant leap in precision and patient safety for minimally invasive spine procedures.
Press Releases